Insider · CIK 0001977746
Lauren Rusckowski Duprey
Files at TAK (TAKEDA PHARMACEUTICAL CO LTD). First filing Aug 12, 2026, latest Sep 15, 2026.
In brief
Lauren Rusckowski Duprey files SEC Form 4 as officer at TAK (TAKEDA PHARMACEUTICAL CO LTD). Since Aug 12, 2026, Lauren Rusckowski Duprey has reported 0 open-market buys worth $0 and 2 open-market sells worth $1.5M, the latest filed on Sep 15, 2026.
A track record needs three past buys with six months of prices behind them; Lauren Rusckowski Duprey has 0, so none is measured yet.
The newest scored trade: sold $640k of TAK on Sep 14, 2026, filed Sep 15, 2026, scored 48 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $1.5M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TAK: TAKEDA PHARMACEUTICAL CO LTD
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | TAKEDA PHARMACEUTICAL CO LTD | $640k 34,535 shares | -15% | - | |
| 57Moderate | TAKEDA PHARMACEUTICAL CO LTD | $814k 47,586 shares | -17% | +33% from low-7% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 10, 2026 | TAK Takeda Pharmaceutical Company Limited | 34,535 0.02% of outstanding | $634k | Sep 10, 2026 | $814k |
| Jul 13, 2026 | TAK Takeda Pharmaceutical Company Limited | 51,579 0.04% of outstanding | $864k | Jul 13, 2026 | none |
| Dec 9, 2025 | TAK Takeda Pharmaceutical Company Limited | 29,619 0.02% of outstanding | $421k | Dec 9, 2025 | none |
| Jul 9, 2025 | TAK Takeda Pharmaceutical Company Limited | 40,919 0.03% of outstanding | $631k | Jul 9, 2025 | none |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 14, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | SOpen-market sale American Depositary Shares | -34,535 | $18.54 | $640k | 191,522 | 28 d ago |
| Aug 10, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | SOpen-market sale American Depositary Shares | -47,586 | $17.10 | $814k | 226,057 | Aug 12, 2026 |
| Jul 1, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award American Depositary Shares | +45,140 | $0.00 | $0 | 273,643 | Jul 6, 2026 |
| Apr 27, 2026 | TAK TAKEDA PHARMACEUTICAL CO LTD | AGrant or award American Depositary Shares | +59,990 | $0.00 | $0 | 228,503 | Apr 28, 2026 |
Questions about Lauren Rusckowski Duprey
Answered from the filings on this page, as of the latest one.
Is Lauren Rusckowski Duprey buying or selling?
In the last 12 months Lauren Rusckowski Duprey reported 0 open-market buys worth $0 and 2 open-market sells worth $1.5M on SEC Form 4; the latest was sold $640k of TAK on Sep 14, 2026. Grants, option exercises and tax withholding are not counted.
How did Lauren Rusckowski Duprey's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lauren Rusckowski Duprey has 0.
Where does Lauren Rusckowski Duprey file Form 4?
Lauren Rusckowski Duprey has filed Form 4 at TAK (TAKEDA PHARMACEUTICAL CO LTD) as Chief Transformation Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.